Glutamine—phenylpyruvate transaminase
Glutamine—phenylpyruvate transaminase (GPT) is an enzyme that plays a crucial role in amino acid metabolism, facilitating the transfer of amino groups between glutamine and phenylpyruvate. This enzyme is part of the broader class of enzymes known as transaminases or aminotransferases, which are pivotal in the synthesis and degradation of amino acids, thus playing a significant role in nitrogen metabolism within the body.
Function[edit | edit source]
The primary function of glutamine—phenylpyruvate transaminase is to catalyze the reversible transamination reaction between glutamine and phenylpyruvate to produce glutamate and phenylalanine. This reaction is vital for the biosynthesis of amino acids, which are essential for protein synthesis and various metabolic processes. GPT activity is crucial in tissues where amino acid synthesis and degradation are significant, such as the liver, muscles, and brain.
Structure[edit | edit source]
Glutamine—phenylpyruvate transaminase, like other transaminases, typically consists of two identical subunits, each containing a pyridoxal phosphate (PLP) cofactor, which is essential for the enzyme's catalytic activity. The structure of GPT is designed to facilitate the transfer of an amino group from glutamine to phenylpyruvate, with the active site of the enzyme specifically recognizing these substrates.
Clinical Significance[edit | edit source]
Alterations in the activity of glutamine—phenylpyruvate transaminase can have significant clinical implications. For instance, abnormal levels of GPT activity can indicate metabolic disorders related to amino acid metabolism. Additionally, since transaminases, including GPT, are involved in nitrogen metabolism, changes in their activity can affect the urea cycle and lead to conditions such as hyperammonemia.
Research[edit | edit source]
Research into glutamine—phenylpyruvate transaminase has focused on understanding its role in metabolic diseases and its potential as a target for therapeutic interventions. Studies have explored how modulation of GPT activity can impact diseases characterized by amino acid metabolism disorders, offering insights into novel treatment strategies.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD